myelodysplastic syndromes
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
myelodysplastic syndromes
Jul 21, 2024, 20:39 |
Blog
Matteo Della Porta: The final analysis of the COMMANDS trial comparing Luspatercept vs Epoetin alfa
Matteo Della Porta, Professor of Hematology at Humanitas University and Head of CALR (Center for…
Jul 15, 2024, 07:03 |
Blog
Amer Zeidan: Our 2nd International Consortium for MDS
Amer Zeidan shared a post on X: . "Our 2nd International Consortium for MDS (icMDS)…
Jul 10, 2024, 07:01 |
Blog
Join MDS Foundation for the Move for MDS Walk
MDS Foundation shared a post on X: "Mark your calendar. . Join us on August…
Jul 8, 2024, 18:33 |
Blog
Sanam Loghavi: Never a better time to be a hematopathologist
Sanam Loghavi shared a post on X: “What better way 2 begin the academic year…
Jul 1, 2024, 09:25 |
Insight
Sylvester cancer expert endorses FDA approval of new drug
The drug, imetelstat, provides a new option for patients suffering from anemia from their cancer.…
Jun 19, 2024, 23:22 |
Blog
Amer Zeidan: Looking forward to finding cures for all AML and MDS patients
Amer Zeidan shared on X: "Looking forward to finding cures for all Acute Myeloid Leukemia…
Jun 18, 2024, 03:11 |
Blog
Amer Zeidan: Dr. Shahram Kordasti detailing the 'immunologic mess' in bone marrow failure conditions
Amer Zeidan shared a post on X: “Dr. Shahram Kordasti detailing the 'immunologic mess' in bone…
Jun 12, 2024, 14:50 |
Blog
Join the 18th International Congress on Myelodysplastic Syndromes in Rotterdam
Join the 18th International Congress on Myelodysplastic Syndromes, happening from May 7-10, 2025, in Rotterdam.…
Jun 7, 2024, 12:04 |
Drugs
Rami Komrokji: Imetelstat approved for MDS patients
Rami Komrokji, Vice Chair of the Malignant Hematology Department at Moffitt Cancer Center, shared a…
May 17, 2024, 01:19 |
Blog
Justin Taylor: Peter Aplan discussing Preclinical Models of MDSsm
Justin Taylor, Assistant Professor at the UM Sylvester Comprehensive Cancer Center, shared on X/Twitter: “Second…
May 16, 2024, 09:22 |
Blog
Amer Zeidan: True pleasure to be in the company of the MDSsm greats
Amer Zeidan shared a post on X: "True pleasure to be in the company of the…
May 13, 2024, 13:48 |
Blog
Rami Komrokji: Combining GenoMed and Moffitt database
Rami Komrokji, Vice chair of the Malignant Hematology Department and the head of the Leukemia…
May 12, 2024, 04:15 |
Blog
Nico Gagelmann: Big achievement in JCO on timing of transplantation for patients with MDS
Nico Gagelmann, Chair of CAR-T for Plasma Cell Disorder Committee and Chair Trainee Committee at The…
Apr 21, 2024, 06:16 |
Dialogues
Oncodaily Dialogues #8 Mikkael Sekeres/ Hosted by Roupen Odabashian
In our ongoing series called “OncoDaily Dialogues”, we consistently feature prominent individuals in the field of…
Apr 16, 2024, 12:47 |
Blog
Ryan Fitzpatrick: Join 30 MPN and MDS KOLs and 30 of their Fellows for a great two day meeting in La Jolla at the Estancia Hotel
Ryan Fitzpatrick, CEO and founder of MD Education, shared a post by MD Education on LinkedIn:…
Apr 8, 2024, 15:14 |
Blog
Uma Borate: Should luspatercept be used as front-line therapy in RS- low-risk transfusion-dependent MDS?
Uma Borate, Acute Leukemia Translation Lead, Associate Professor at OHSU, shared on X: "Fantastic start…
Mar 16, 2024, 15:53 |
Drugs
Blood Cancer Expert Dr. Mikkael Sekeres Endorses FDA Approval of New Drug, Imetelstat
Dr. Mikkael Sekeres is an expert in blood cancers at Sylvester Comprehensive Cancer Center - University of…
Mar 11, 2024, 03:24 |
Career
Amer Zeidan was appointed as the inaugural Chief of the Division of Hematologic Malignancies at Yale Cancer Center
Yale Cancer Center shared on LinkedIn: "We are pleased to announce that Amer Zeidan was…
Dec 22, 2023, 14:59 |
Blog
Our 29 Working Groups and their coordinators - AIEOP
The Italian Association of Pediatric Hematology and Oncology (AIEOP) shared on LinkedIn: "TO ALL OUR…
Nov 3, 2023, 12:29 |
Insight
Talha Badar: In view of recent approval of IDH1i in MDS brief tweetorial
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Oct 31, 2023, 15:38 |
Insight
Susan Pandya: U.S. FDA approval of our targeted therapy underscores the efforts of our exceptional clinical research team
Susan Pandya, Vice President of Clinical Development and Global Head of Cancer Metabolism at Servier…
Oct 30, 2023, 19:30 |
Stories
We're highlighting Imani’s story and her full circle moment from pediatric Blood Cancer patient to nurse - The Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society shared a post on Linkedin: "'I was diagnosed with myelodysplastic syndrome…
Sep 17, 2023, 17:27 |
Blog
Avi Steindel: SparkCures has launched a partnership with the MDS Foundation to revolutionize clinical trial matching for people living with myelodysplastic syndromes (MDS) and related diseases.
Jun 1, 2023, 02:37 |
Drugs
Luspatercept: A Transformative Therapy for Transfusion-Dependent Myelodysplastic Syndromes
Luspatercept is a transformative therapy for patients with transfusion-dependent myelodysplastic syndromes (MDS). Esteemed oncologist, Dr.…
All:
24
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube